Showing 661 - 680 results of 916 for search '"type 2 diabetes mellitus"', query time: 0.12s Refine Results
  1. 661

    Рerioperative period of high-risk patients with coronary artery disease by O.K. Gogayeva

    Published 2021-07-01
    “…Among comorbid conditions, type 2 diabetes mellitus was diagnosed in 50 (25.7 %) patients, impaired glucose tolerance – in 82 (42.2 %) patients, obesity – in 74 (38.1 %) patients, 86 (44.3 %) patients were overweight with a body mass index 25–29.9 kg/m2, and 75 (38.6 %) patients were diagnosed with chronic kidney disease. …”
    Get full text
    Article
  2. 662

    Structural and Biomechanical Corneal Differences between Type 2 Diabetic and Nondiabetic Patients by João N. Beato, João Esteves-Leandro, David Reis, Manuel Falcão, Vítor Rosas, Ângela Carneiro, Fernando Falcão Reis

    Published 2019-01-01
    “…To analyze and compare corneal structural and biomechanical properties, characterized by corneal hysteresis (CH) and resistance factor (CRF), between patients with and without type 2 diabetes mellitus (DM), and determine the main ocular variables that influence them. …”
    Get full text
    Article
  3. 663

    Green and High Throughput Assay Using 96-Microwell Base to Determine Metformin Hydrochloride in the Tablet Dosage Form by Mohammed Alqarni, Atheer Alshehri, Bayan Almalki, Refah Althumali, Maram Alghamdi, Rawan Alqahtani, Safia G. Alotibi, Ali Alqarni, Adel H. Awad, Ibrahim A. Naguib

    Published 2024-01-01
    “…Metformin (MET) is an oral antidiabetic drug widely used as the primary treatment for type 2 diabetes mellitus (T2DM). While various spectrophotometric assays exist for determining MET in pharmaceutical formulations, they often have limited throughput for quality control purposes. …”
    Get full text
    Article
  4. 664

    When to Consider a Diagnosis of Maturity-Onset Diabetes of the Young: Precise Diagnosis Leads to Better Management and Quality of Life for the Patients by Yujia Gao, Kalyan Mansukhbhai Shekhda, Sarah N. Ali

    “…We present three cases initially diagnosed as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and fasting hyperglycemia, which were later identified as MODY. …”
    Get full text
    Article
  5. 665

    Correlation Analysis between Nerve Fiber Layer Thickness and Peripapillary Vessel Density and Influencing Factors of Peripapillary Vessel Density in Preclinical Diabetic Retinopath... by Donghui Li, Qichang Wang

    Published 2020-01-01
    “…Thirty-four eyes of 34 type 2 diabetes mellitus (T2DM) patients diagnosed with preclinical diabetic retinopathy (DR) were included in our study, with twenty-three eyes of 23 healthy subjects set up as normal controls. …”
    Get full text
    Article
  6. 666

    Diabetes mellitus educational intervention in patients at risk from a medical office. Nuevitas, 2020-2023 by Maigret Calderón Cruz, Julio Michel Arias Manganelly, Olenis Alicia Aldana Ramos, Lieter Ailed Vidal Rodríguez, Pedro Figueredo Guerra, Aned Hernández Clavijo

    Published 2024-05-01
    “…<br /><strong>Objective</strong>: to describe an educational intervention on type 2 diabetes mellitus results in patients with risk factors.…”
    Get full text
    Article
  7. 667

    Correlation between plasma glutamate and adiponectin in patients with type 2 diabetes by Hirofumi Nagao, Hitoshi Nishizawa, Shiro Fukuda, Yuya Fujishima, Shunbun Kita, Norikazu Maeda, Takeshi Bamba, Eiichiro Fukusaki, Iichiro Shimomura

    Published 2024-01-01
    “…Visceral fat accumulation is a major determinant of type 2 diabetes mellitus and cardiovascular diseases. Recent studies have reported that glutamate is the most elevated amino acid in the plasma amino acid profile in patients with obesity and/or visceral fat accumulation. …”
    Get full text
    Article
  8. 668

    Effect of Liraglutide on Serum TSH Levels in Patients with NAFLD and its Underlying Mechanisms by JiaoJiao Ye, Jing Xu, WenJie Wen, Bin Huang

    Published 2022-01-01
    “…This study aimed to evaluate the effect of liraglutide on serum thyroid-stimulating hormone (TSH) levels in patients with type 2 diabetes mellitus (T2DM) and explore the underlying mechanisms via bioinformatics analysis. …”
    Get full text
    Article
  9. 669

    Pengaruh Kombinasi Metformin dan Ekstrak Kunyit terhadap Kadar High Density Lipoprotein, Interleukin-6 dan Tumor Necrosis Factor-a by Fathia Kesuma Dinanti, Sri Priyantini Mulyani, Chodidjah - -

    Published 2023-04-01
    “…A  decrease in high-density lipoprotein (HDL) happens in type 2 diabetes mellitus. The cytokines TNFa and IL-6 are proinflammatory cytokines that are elevated in the blood in many patients with DM. …”
    Get full text
    Article
  10. 670

    Squamous Cell Carcinoma of Nasofacial Groove by Tamajit Sau, Saumitra Kumar, Ankita Atin Mukherjee, Debalina Mazumdar

    Published 2024-05-01
    “…Case Report: A 65-year-old housewife with hypertension and type 2 Diabetes Mellitus presented with painless swelling over right nasofacial groove for last 5 months which was insidious in onset, gradually progressive to reach the present size. …”
    Get full text
    Article
  11. 671

    The Effect of Shear Force on Skin Viability in Patients with Type 2 Diabetes by Luuk A. de Wert, Margot Geerts, Sander van der Brug, Laura Adriaansen, Martijn Poeze, Nicolaas Schaper, Nicole D. Bouvy

    Published 2019-01-01
    “…Shear is a major risk factor in the development of diabetic foot ulcers, but its effect on the skin of patients with type 2 diabetes mellitus (DM) remains to be elucidated. The aim was to determine skin responses to shear in DM patients with and without diabetic polyneuropathy (DNP). …”
    Get full text
    Article
  12. 672

    Characteristics and Clinical Course of Patients with Acute Myocardial Infarction and ST-segment Elevation with and without Interatrial Block by Francisco de Jesús Valladares Carvajal, Verónica Mercedes Carretero Acosta, Raimundo Carmona Puerta, Aymara Marcia Hernández Cardoso, Ernesto Julio Bernal Valladares

    Published 2023-08-01
    “…Demographic variables were analyzed: age, sex, skin color and between clinics: toxic habits; (smoker, ex-smoker); medical history (myocardial infarction, angina, peripheral arterial disease, arterial hypertension, type 2 diabetes mellitus, chronic kidney disease; infarct location (anterior, inferior, left bundle branch block); complications: heart failure, atrial fibrillation, ventricular tachycardia/ventricular fibrillation, atrioventricular conduction disorders, mechanical complication, post infarction angina, arterial embolism) and discharge status (alive or deceased). …”
    Get full text
    Article
  13. 673

    Ficus carica and Sizigium cumini Regulate Glucose and Lipid Parameters in High-Fat Diet and Streptozocin-Induced Rats by El-Shaimaa A. Arafa, Waseem Hassan, Ghulam Murtaza, Manal Ali Buabeid

    Published 2020-01-01
    “…Results showed that both FC.Cr. and SC.Cr. have the potential to control obesity-linked type 2 diabetes mellitus (T2DM) by lowering the body weights, serum glucose, cholesterol, TG, LDL, and VLDL, while increasing the protective effects of HDL dose-dependently. …”
    Get full text
    Article
  14. 674

    Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy by Joselyn Rojas, Valmore Bermudez, Jim Palmar, María Sofía Martínez, Luis Carlos Olivar, Manuel Nava, Daniel Tomey, Milagros Rojas, Juan Salazar, Carlos Garicano, Manuel Velasco

    Published 2018-01-01
    “…Describing the diverse molecular mechanisms (particularly immunological) involved in the death of the pancreatic beta cell in type 1 and type 2 diabetes mellitus. Recent Findings. Beta cell death is the final event in a series of mechanisms that, up to date, have not been entirely clarified; it represents the pathophysiological mechanism in the natural history of diabetes mellitus. …”
    Get full text
    Article
  15. 675

    Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway by Jie Yu, Yuan Zhao, Lingling Xu, Wei Li, Huabing Zhang, Fan Ping, Yuxiu Li

    Published 2023-01-01
    “…Liraglutide has been extensively applied in the treatment of type 2 diabetes mellitus and also has hepatoprotective effects. …”
    Get full text
    Article
  16. 676

    Choroidal Thickness and Urinary Albumin Excretion in Type 2 Diabetic Patients without Retinopathy by Cláudia Oliveira-Ferreira, Mariana Leuzinger-Dias, João Tavares-Ferreira, F. Falcão-Reis, Amândio Rocha-Sousa

    Published 2020-01-01
    “…Inclusion criteria were diagnosis of type 2 diabetes mellitus, absence of diabetic retinopathy, and a 24 hours urinary albumin measurement in the last 3 months at the primary health-care center. …”
    Get full text
    Article
  17. 677

    Role of platelet indices and vitamin D in forecasting deterioration of glycemic control and vascular complications in type 2 diabetes by Maryam Ahmed Obaid Al Ali, Khalid Abdelsamea Mohamedahmed, Asaad Ma Babker

    Published 2025-01-01
    “… Type 2 diabetes mellitus (T2DM) is a prevalent chronic condition associated with various complications, including vascular ones. …”
    Get full text
    Article
  18. 678

    Electrochemical Skin Conductance May Be Used to Screen for Diabetic Cardiac Autonomic Neuropathy in a Chinese Population with Diabetes by Tianyi He, Chuan Wang, Anju Zuo, Pan Liu, Ruxing Zhao, Wenjuan Li, Li Chen, Xinguo Hou

    Published 2017-01-01
    “…We recruited 75 patients with type 2 diabetes mellitus (T2DM) and 45 controls without diabetes. …”
    Get full text
    Article
  19. 679

    Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes by Feihui Zeng, Lingning Huang, Yongze Zhang, Xinyu Hong, Suiyan Weng, Ximei Shen, Fengying Zhao, Sunjie Yan

    Published 2022-01-01
    “…A cross-sectional study was conducted involving 4673 hospitalized patients (2271 men and 2402 women) with type 2 diabetes mellitus, with an average age of 60.66±11.93 years, of whom 542 were followed up for a median follow-up period of 24 months. …”
    Get full text
    Article
  20. 680

    Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study) by Sunghwan Suh, Sun Ok Song, Jae Hyeon Kim, Hyungjin Cho, Woo Je Lee, Byung-Wan Lee

    Published 2017-01-01
    “…The present observational study aimed to evaluate the clinical effectiveness of vildagliptin with metformin in Korean patients with type 2 diabetes mellitus (T2DM). Data were pooled from the vildagliptin postmarketing survey (PMS), the vildagliptin/metformin fixed drug combination (DC) PMS, and a retrospective observational study of vildagliptin/metformin (fixed DC or free DC). …”
    Get full text
    Article